Cite

HARVARD Citation

    Campbell, J. et al. (2016). Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung. MAbs. 8 (7), pp. 1398-1406. [Online]. 
  
Back to record